These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3498419)

  • 41. [Etiology and pathogenesis of inflammatory bowel diseases].
    Schölmerich J
    Praxis (Bern 1994); 2002 Nov; 91(47):2017-22. PubMed ID: 12501496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Differential diagnosis of chronic inflammatory bowel diseases. Possibilities and limits of morphology].
    von Herbay A; Otto HF
    Chirurg; 1992 Jan; 63(1):1-7. PubMed ID: 1547638
    [No Abstract]   [Full Text] [Related]  

  • 43. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease.
    Evans JM; McMahon AD; Murray FE; McDevitt DG; MacDonald TM
    Gut; 1997 May; 40(5):619-22. PubMed ID: 9203940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TNF alpha secreting cells in normal and diseased human intestine.
    Breese E; MacDonald TT
    Adv Exp Med Biol; 1995; 371B():821-4. PubMed ID: 7502905
    [No Abstract]   [Full Text] [Related]  

  • 45. Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn's disease.
    Coruzzi P; Castiglioni P; Parati G; Brambilla V; Brambilla L; Gualerzi M; Cademartiri F; Franzè A; De Angelis G; Di Rienzo M; Di Mario F
    Eur J Clin Invest; 2007 Dec; 37(12):964-70. PubMed ID: 18036030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors associated with disease evolution in Greek patients with inflammatory bowel disease.
    Chatzicostas C; Roussomoustakaki M; Potamianos S; Paspatis G; Mouzas I; Romanos J; Mavrogeni H; Kouroumalis E
    BMC Gastroenterol; 2006 Jul; 6():21. PubMed ID: 16869971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory bowel disease-related lesions in the duodenal and gastric mucosa.
    Danelius M; Ost A; Lapidus AB
    Scand J Gastroenterol; 2009; 44(4):441-5. PubMed ID: 19110988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Morphological and immunohistochemical characteristic of oral mucosa in patients with inflammatory bowel disease].
    Kvetnoĭ IM; Robakidze NS; Kostiuchek IN; Shchukina OB; Proshchaev KI
    Adv Gerontol; 2010; 23(3):371-4. PubMed ID: 21137207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Detection of increased permeability of the intestinal mucosa in chronic inflammatory bowel diseases].
    Karbach U
    Z Gastroenterol Verh; 1989 Jul; 24():40-4. PubMed ID: 2474980
    [No Abstract]   [Full Text] [Related]  

  • 50. Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity.
    Walsh A; Palmer R; Travis S
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):367-78. PubMed ID: 24975528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adverse effects of nonsteroidal anti-inflammatory drugs on the small and large bowel.
    Schneider AR; Benz C; Riemann JF
    Endoscopy; 1999 Nov; 31(9):761-7. PubMed ID: 10604623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Numerical taxonomy and discriminant analysis applied to non-specific colitis.
    Jones JH; Lennard-Jones JE; Morson BC; Chapman M; Sackin MJ; Sneath PH; Spicer CC; Card WI
    Q J Med; 1973 Oct; 42(168):715-32. PubMed ID: 4606853
    [No Abstract]   [Full Text] [Related]  

  • 53. Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation.
    Bortlik M; Duricova D; Machkova N; Hruba V; Lukas M; Mitrova K; Romanko I; Bina V; Malickova K; Kolar M; Lukas M
    Scand J Gastroenterol; 2016; 51(2):196-202. PubMed ID: 26329773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. VEGF contributes to ulcerative colitis pathogenesis.
    J Pharmacol Exp Ther; 2009 Mar; 328(3):681. PubMed ID: 19233939
    [No Abstract]   [Full Text] [Related]  

  • 55. Endoscopy in inflammatory bowel disease: advances in dysplasia detection and management.
    Kaltenbach T; Sandborn WJ
    Gastrointest Endosc; 2017 Dec; 86(6):962-971. PubMed ID: 28987547
    [No Abstract]   [Full Text] [Related]  

  • 56. [Surgical indications in ulcerative colitis and Crohn disease].
    Lausen M; Spamer C
    Fortschr Med; 1991 Apr; 109(11):238-41. PubMed ID: 1713186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.
    Nissen LH; Nagtegaal ID; de Jong DJ; Kievit W; Derikx LA; Groenen PJ; van Krieken JH; Hoentjen F
    J Crohns Colitis; 2015 May; 9(5):398-403. PubMed ID: 25740811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biopsy histamine in ulcerative colitis and Crohn's disease.
    Baenkler HW; Lux G; Günthner R; Kohlhäufl M; Matek W
    Hepatogastroenterology; 1987 Dec; 34(6):289-90. PubMed ID: 3428863
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathology of inflammatory bowel disease.
    Gramlich T; Petras RE
    Semin Pediatr Surg; 2007 Aug; 16(3):154-63. PubMed ID: 17602970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mucosal healing in inflammatory bowel disease.
    Osterman MT
    J Clin Gastroenterol; 2013 Mar; 47(3):212-21. PubMed ID: 23340060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.